Orasure Technologies Inc. OSUR

NAS: OSUR | ISIN: US68554V1089 7/06/2023

5,500 USD (+0,18%)

(+0,18%) 7/06/2023

Toon enkel gratis nieuws

25 januari 2022 · OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe · Persbericht

1 maart 2021 · OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update · Persbericht

24 februari 2021 · OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference · Persbericht

18 februari 2021 · 2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET · Persbericht

29 januari 2021 · OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test · Persbericht

28 januari 2021 · OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing · Persbericht

21 januari 2021 · OraSure’s Oragene®•Dx Saliva Collection Kit Included in Industry’s First FDA Authorization for a Whole Exome Sequencing Platform · Persbericht

8 januari 2021 · OraSure Technologies Announces 2021 Annual Meeting Date · Persbericht

5 januari 2021 · OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe